X4 Pharmaceuticals, Inc. beat EPS estimates 100% of the time across 1 reported quarters (1 beats, 0 misses). Data sourced from SEC EDGAR.
| Quarter | EPS Estimate | EPS Actual | Surprise | Result |
|---|---|---|---|---|
| Q12026 FY2026 | $-0.20 | $-0.16 | +20.0% | Beat |
Back to XFOR overview · XFOR holders · XFOR KPIs
Data sourced from U.S. SEC EDGAR filings. Not personalized investment advice.